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AbstrAct
Objectives For very preterm births, to compare 
alternative policies for umbilical cord clamping and 
immediate neonatal care.
Design Parallel group randomised (1:1) trial, using 
sealed opaque numbered envelopes.
setting Eight UK tertiary maternity units.
Participants 261 women expected to have a live birth 
before 32 weeks, and their 276 babies.
Interventions Cord clamping after at least 2 min and 
immediate neonatal care with cord intact, or clamping 
within 20 s and immediate neonatal care after clamping.
Main outcome measures Intraventricular 
haemorrhage (IVH), death before discharge.
results 132 women (137 babies) were allocated 
clamping ≥2 min and neonatal care cord intact, and 
129 (139) clamping ≤20 s and neonatal care after 
clamping; six mother-infant dyads were excluded (2, 
4) as birth was after 35+6 weeks, one withdrew (death 
data only available) (0, 1). Median gestation was 28.9 
weeks for those allocated clamping ≥2 min, and 29.2 
for those allocated clamping ≤20 s. Median time to 
clamping was 120 and 11 s, respectively. 7 of 135 infants 
(5.2%) allocated clamping ≥2 min died and 15 of 135 
(11.1%) allocated clamping ≤20 s; risk difference (RD) 
−5.9% (95% CI −12.4% to 0.6%). Of live births, 43 of 
134 (32%) had IVH vs 47 of 132 (36%), respectively; 
RD −3.5% (−14.9% to 7.8%). There were no clear 
differences in other outcomes for infants or mothers.
conclusions This is promising evidence that clamping 
after at least 2 min and immediate neonatal care with 
cord intact at very preterm birth may improve outcome; a 
large trial is urgently needed.
trial registration ISRCTN 21456601.
IntrODuctIOn
At birth, if the umbilical cord is not clamped blood 
flow between baby and placenta may continue for 
several minutes.1–3 This umbilical flow is part of 
the physiological transition from the fetal to the 
neonatal circulation; clamping the cord too soon 
may restrict the infant’s ability to cope with this 
transition.2 4–8 A short delay in cord clamping may 
increase neonatal blood volume, a longer delay 
of several minutes may have more substantive 
advantages, such as smoother cardiorespiratory 
transition and more stable blood pressure, which 
for very preterm infants (<32 weeks gestation) 
may reduce the risk of intraventricular haemor-
rhage.9 10 Concerns about deferring (delaying) 
cord clamping include exacerbating jaundice, 
polycythaemia, delayed respiratory support and 
hypothermia.
The relevant Cochrane review suggests that for 
infants born preterm deferring cord clamping may 
improve outcomes at hospital discharge.11 However, 
the 15 trials included were small and have a high 
risk of bias. None were prospectively registered, 
and they reported different outcomes, so the possi-
bility of selective outcome reporting is high. Also, 
data on long-term safety are sparse. Importantly, 
these studies excluded infants requiring resusci-
tation at birth, and for very preterm births most 
trials deferred clamping for <60 s. Guidelines for 
very preterm birth make various recommendations 
about when to clamp the cord,12–14 and advise that 
clamping should not be delayed if neonatal resus-
citation is required.14 15 Evaluating timing of cord 
clamping at very preterm birth is a research priority, 
particularly for infants requiring resuscitation at 
birth.15–17
Our hypothesis is that for very preterm births 
a policy of cord clamping after at least 2 min and 
providing immediate neonatal care with cord 
intact, rather than usual care of clamping within 
20 s and neonatal care after clamping, improves 
outcome for the infants without adverse effects for 
What this study adds?
 ► Neonatal stabilisation and resuscitation can be 
provided with the cord intact.
 ► Giving neonatal care with the cord intact may 
improve outcome for the infants born very 
preterm.
 ► The effect of resuscitating preterm babies with 
an intact cord needs to be addressed in a large 
multicentre trial.
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What is already known on this topic?
 ► If the umbilical cord is not clamped flow 
continues for longer than previously thought, 
and cord pulsation does not correlate with 
umbilical flow.
 ► A short delay in cord clamping may reduce 
the risk of intraventricular haemorrhage and 
improve outcome in preterm babies.
 ► Previous small trials excluded babies requiring 
resuscitation at birth.
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Figure 1 Participant flow.
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the women. Having developed strategies for providing stabilisa-
tion and resuscitation with the cord intact,18 19 we conducted a 
randomised trial.
MethODs
trial design and changes since trial registration
This pragmatic randomised parallel group trial was conducted 
at eight UK tertiary maternity units with a neonatal intensive 
care unit. The protocol is published20 along with an update,21 
and these are summarised here. Initially, the study aimed to assess 
the feasibility of a large multicentre trial and planned to recruit 
for 1 year. Feasibility was demonstrated and, on the advice of the 
independent Trial Steering Committee, recruitment continued 
while funding was sought for the main trial. Recruitment closed 
in February 2015 when the funding application was unsuccessful. 
The sponsor is Nottingham University Hospitals NHS Trust. Trial 
coordination was at the Nottingham Clinical Trials Unit (NCTU).
As the original protocol was for a pilot trial, outcomes were 
measures of feasibility and analysis by allocated group was not 
planned. The statistical analysis plan (SAP) for the extended 
study was agreed before data were unblinded. For the planned 
main trial, main outcomes were death before discharge and 
intraventricular haemorrhage (all grades), hence these were the 
main outcomes in this SAP. Data presented here are for outcomes 
at discharge. Follow-up for women at 1 year, and for children at 
age 2 years (corrected for gestation) will be reported separately.
Parent and parent representative involvement
Three parent representatives were coinvestigators, involved in 
identifying the research question, securing funding and designing 
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and conducting the study. They advised on plans for recruitment; 
contributed to developing the oral assent pathway; advised on 
study implementation and conduct; participated in investigator 
meetings, including training in explaining the study to women 
and offering consent and contributed to interpretation and 
writing up of results. Two parents were independent members of 
the Trial Steering Committee. Participants in the trial have been 
thanked for participation, asked for their views of participation 
and updated on progress. When results are published they will 
be summarised in lay language.
Participants
Women were eligible if they were expected to have a live birth 
before 32 weeks gestation, regardless of mode of birth or fetal 
presentation. Exclusion criteria were monochorionic twins; 
triplets or higher-order multiple pregnancy and known major 
congenital malformation.
Interventions
Umbilical cord clamping after at least 2 min and, if needed, imme-
diate neonatal stabilisation and resuscitation with cord intact 
was compared with clamping within 20 s and, if needed, imme-
diate neonatal stabilisation and resuscitation after clamping. 
Waiting at least 2 min before clamping was based on a balance 
between waiting until umbilical flow ceased (which may take 
3–5 min, or longer),2 3 8 22 and what was acceptable to clinicians. 
For the intervention group, with cord intact babies were placed 
onto a firm surface with easy access to resuscitation equipment; 
either the usual equipment19 or a smaller trolley designed for 
this purpose23 moved alongside the mother’s bed. For caesarean 
births, the neonatal resuscitation equipment was covered with 
sterile drapes, and the neonatologist scrubbed and gowned. For 
both groups, after cord clamping neonatal care was either beside 
the mother or at the usual location (side of the room or sepa-
rate room), at the discretion of the local clinicians. Six sites used 
their usual resuscitation equipment (153 women recruited) and 
two the trolley (108). Until cord clamping, the baby was kept 
at the level of placenta (introitus or mothers’ abdomen, or if a 
caesarean birth the anterior thigh). Clamping within 20 s with 
stabilisation and resuscitation after cord clamping was based on 
the current UK practice,24 and previous trials.11
For both groups, all other aspects of care including intubation 
and respiratory support were at the discretion of the attending 
clinicians. Neonatal care was based on local unit policy and 
consistent with Resuscitation Council (UK) newborn life support 
guidelines.14 25 Standard equipment was used according to 
local practice, including plastic sheets or bags, towels and hats, 
warming mattresses or overhead heaters and saturation monitors.
Outcome measures
Main outcomes were death before hospital discharge and intra-
ventricular haemorrhage (all grades using the Papile classifica-
tion26). A single assessor reviewed the cranial ultrasound scan 
reports for intraventricular haemorrhage, blind to the allocated 
group. Then eight trained clinicians (neonatologists or radiol-
ogists) independently adjudicated each scan, blind to alloca-
tion.27 If the adjudication disagreed with the scan report review, 
a second independent adjudicator assessed the scan images. 
Remaining discrepancies were resolved by discussion.
Other outcomes for the baby were: severe intraventricular 
haemorrhage,26 periventricular leukomalacia, blood trans-
fusion, hypothermia (<36°C, <35°C), chronic lung disease 
(supplemental oxygen or ventilator support at 36 weeks 
postmenstrual age), ventilation, necrotising enterocolitis 
(grade 2 or higher), clinical sepsis, treatment for jaundice, 
treatment for patent ductus arteriosus, treatment for reti-
nopathy of prematurity and duration of hospital stay.
Outcomes for women were: postpartum haemorrhage (≥500 
or ≥1000 mL), postpartum infection, breast feeding and for 
vaginal births manual removal of placenta and third stage of 
labour longer than 30 min. Data were collected up to discharge 
by research staff at site.
recruitment and randomisation
Study information was available in antenatal clinics and wards. 
Women at risk of very preterm birth were offered participa-
tion, and if they accepted gave written consent. Eligibility and 
consent were checked before randomisation, which was during 
labour or before caesarean section. If birth was imminent and 
the attending clinician considered it appropriate, women were 
offered a brief explanation of the study and offered participation 
(oral assent). Those who gave oral assent were then randomised. 
After the birth, these women had an opportunity to discuss the 
study and were invited to give written consent for participation 
in follow-up.
Randomisation was by attending clinicians, who took 
the next sealed consecutively numbered opaque envelope 
from a ringbinder folder. Sequence generation (1:1) was 
by computer, stratified by centre with balanced blocks of 
randomly varying size, created by NCTU. On the envelope 
was a label to record the date, time, woman’s initials, her 
date of birth and gestation. Once this label was completed 
she was randomised, even if the envelope was not opened. 
Inside the envelope was a yellow card instructing when 
to clamp the cord, and a ‘Birth Record’ (plus a second 
for twins) to record information about the third stage of 
labour and neonatal care at birth. This was completed by 
clinical staff, and filed in the baby’s medical notes. Used 
envelopes and yellow cards were placed in a locked mailbox, 
which was emptied regularly. Details from each envelope 
were entered into the online randomisation log maintained 
by NCTU. If an envelope was taken but not used, it was 
returned unopened to NCTU.
During the last few months of recruitment, a secure web-based 
randomisation system, using the same randomisation sequence, 
was introduced in three sites to assess its feasibility.
sample size
Based on a total of 43 600 live births per year at the eight mater-
nity units, we expected 610 (1.4%)28 live births to be before 
32 weeks; as target accrual was 16%–18% of eligible births we 
anticipated 100–110 women randomised per year. This was 
planned as a pilot trial so there was no formal power calculation.
statistical analysis
All analyses are based on the groups as randomly allo-
cated (intention to treat). For twin pregnancies, outcome 
is reported for both babies. Where appropriate, results are 
presented as relative risk (RR) or risk difference (RD) with 
95% CIs. Women who were randomised but gave birth 
after 35+6 weeks are excluded, as outcomes for these babies 
are different from those born very preterm. For secondary 
outcomes, missing data for individual items are only 
reported if they exceeded 1% of total data available. No 
formal interim analysis was planned. Data were monitored in 
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table 1 Baseline characteristics for the women
clamp ≥2 
min+neonatal 
care with cord 
intact
clamp ≤20 
s+neonatal 
care after 
clamping
(n=130) (n=124)
Gestation at randomisation (weeks) ≥32 1 (1%) 1 (1%)
30 to 31+6 44 (34%) 46 (37%)
28 to 29+6 38 (29%) 42 (34%)
26 to 27+6 25 (19%) 21 (17%)
<26 22 (17%) 14 (11%)
Gestation at birth (weeks) ≥32 2 (2%) 2 (2%)
30 to 31+6 47 (36%) 44 (35%)
28 to 29+6 35 (27%) 43 (35%)
26 to 27+6 25 (19%) 21 (17%)
<26 21 (16%) 14 (11%)
Age (years), mean (SD)   30.3 (6.1)  29.2 (6.6)
Primiparous 69 (53%) 75 (60%)
Twin pregnancy *7 (5%) 10 (8%)
Pregnancy complications
Prelabour rupture of membranes 43 (33%) 40 (32%)
Spontaneous onset of labour 31 (24%) 33 (27%)
CTG abnormalities/fetal distress 21 (16%) 23 (19%)
Pre-eclampsia/PIH 33 (25%) 24 (19%)
Antepartum haemorrhage/placenta previa 14 (11%) 18 (15%)
Chorioamnionitis 15 (12%) 14 (11%)
Fetal growth restriction/small for gestational age 13 (10%) 13 (10%)
Other† 5 (4%) 6 (5%)
In last week received
Magnesium sulfate 67 (52%) 49 (40%)
Not known 4 (3%) –
Corticosteroids 117 (90%) 111 (90%)
Caesarean section 82 (63%) 67 (54%)
Before labour   69  57
During labour   13  10
Vaginal birth 48 (37%) 57 (46%)
Breech presentation    9   8
*For two, one twin known intrauterine death before randomisation.
†Clamp ≤20 s: abdominal pain (n=2), severe asthma (1), pyelonephritis (1), 
antiphosphate lipid syndrome (1) and not known (1). Clamp ≥2 min: renal failure 
and diabetes (1), previous cervical surgery (1), coagulopathy (1), Crohn’s disease (1) 
and hypotension (1).
CTG, cardiotocograph; PIH, pregnancy-induced hypertension.
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confidence by an independent Data Monitoring Committee, 
which met four times.
results
Of 945 women approached, 472 (50%) gave consent (figure 1). 
Oral assent was offered to 93 women, of whom 84 (90%) 
assented and of these 77 were randomised. For eight of the 77 
women randomised following oral assent birth was not immi-
nent as anticipated, and written consent was given before birth, 
hence 69 were randomised with oral assent only (33 cord 
clamping ≥2 min, 36 clamping ≤20 s). For 66 of these women 
written consent was given after the birth; written consent was 
not obtained for three, for two their baby died and they did 
not return for their counselling appointment at which written 
consent would have been sought and one was transferred to 
another unit.
Recruitment was from March 2013 to February 2015, and 
261 women were randomised (132 cord clamping after at 
least 2 min, 129 within 20 s). Six women were excluded as they 
gave birth after 35+6 weeks and one withdrew (outcome data 
reported only for death before discharge), leaving 254 women 
for analysis (figure 1). In 2 of the 17 twin pregnancies, one fetus 
died in utero before randomisation, so 269 babies are included 
in analysis. Time between randomisation and birth was within 
30 min for 81 women (32%), within 1 hour for 128 (50%) and 
within 2 hours for 178 (70%); 20 (8%) gave birth 24 hours or 
more after randomisation.
baseline characteristics
The groups were balanced at trial entry (table 1). A third of 
women were randomised before 28 weeks, and two-thirds 
before 30 weeks. One hundred forty-four (57%) were in their 
first pregnancy and just over half had a caesarean birth. Of the 
babies, 143 (53%) were males (71/135 clamping after ≥2 min vs 
72/134 clamping ≤20 s).
compliance with the allocated intervention
Median time to cord clamping was 120 s (IQR 36–134), for those 
allocated clamping after at least 2 min and neonatal care with 
cord intact, and 11 s for those allocated clamping within 20 s and 
neonatal care after clamping (IQR 10–20). In the intervention 
group, cord clamping was after at least 2 min for 80 (59%) babies 
and after 20 s for 111 (82%) (figure 2). Baseline characteristics 
were similar for babies with cord clamping after at least 2 min 
and those clamped before 2 min; for example, gestation at birth 
28+0 to 31+6 weeks 64% vs 63%, respectively; antenatal cortico-
steroids 87% vs 94% and caesarean birth 61% vs 67%. For the 
55 babies for whom clamping was before 2 min, reasons were: 
cord too short (21, 38%), an issue that improved with experi-
ence; clinical decision (12, 22%); baby born either membranes 
intact or with the placenta (8, 15%); placental abruption (5, 
9%); neonatal team not there in time (4, 7%); staff error (4, 7%) 
and cord snapped (1, 2%). In the control group, cord clamping 
was within 20 s for 126 (94%). There were no clear differences 
in compliance based on whether the site used usual resuscitation 
equipment or the trolley (data not shown). Neonatal care was 
comparable between the two allocated groups (table 2). For live-
born babies, median birth weight was 1108 g (IQR 880–1360) 
in the intervention group and 1180 g (IQR 900–1418 g) in the 
control group (figure 2).
A prophylactic uterotonic drug was given to 127 women 
(98%) allocated clamping after at least 2 min, and 120 (97%) 
allocated clamping within 20 s. Administration was before cord 
clamping for 40 (31%) and 15 (12%), respectively; however, 
timing was unknown for 47 (37%) and 34 (28%).
Outcome for babies
Overall, 7/135 (5.2%) babies allocated clamping after at least 
2 min and neonatal care with cord intact died compared with 
15/135 (11.1%) allocated clamping within 20 s and neonatal 
care after clamping (table 3), RR 0.47 (95% CI 0.20 to 1.11); 
RD −5.9% (−12.4% to 0.6%). The only death of an infant 
born after 30 weeks gestation was due to congenital anomaly 
that was not known before randomisation (if it had been the 
woman would not have been eligible). Excluding this death gives 
RR 0.50 (0.21 to 1.20), and RD −5.2% (-11.5% to 1.2%). The 
three stillbirths were born before 28 weeks, and were resusci-
tated at birth; cause of death was intrapartum asphyxia for two, 
and antepartum infection for one.
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Figure 2 Actual timing of cord clamping for each baby in the two allocated groups. *n=135 babies, seconds to cord clamping not known for 9. 
**n=134 babies, seconds to cord clamping not known for 9. 
table 2 Neonatal care and newborn life support at birth
clamp ≥2 min+neonatal care with cord intact
(n=135) clamp ≤20 s+neonatal care after clamping (n=134)
beside mother
Away from 
mother total beside mother
Away from 
mother total
Baby in plastic bag/sheet 100* 15 115 (85%) 41* 67 108 (81%)
Mask ventilation 68 32 100 (74%) 14 89  105† (78%)
Supplemental oxygen 46 38 84 (62%)  9 79  89‡ (66%)
Airway suction 39 36 75 (56%) 10 76  87‡ (65%)
Successful intubation 38 40 78 (58%) 10 77 87 (65%)
Surfactant 28 39 67 (50%)  9 66 75 (56%)
Attempted, unsuccessful intubation 20 15 35 (26%)  5 33 38 (28%)
Continuous positive airway pressure 27 17 44 (33%)  – 34 34 (25%)
Cardiac massage  3  3 6 (4%)  3  7 10 (7%)
Umbilical venous catheterisation  1  2 3 (2%)  –  6 6 (4%)
Other  – 1§ 1 (1%)  –  – –
*Placed in plastic bag beside mother, received all other care at roomside; n=14 clamp ≥2 min, n=26 clamp ≤20 s.
†Location not known for two.
‡Location not known for one.
§Packed cell transfusion.
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Of live births allocated to the intervention, 43/134 (32%) had 
an IVH versus 47/132 (36%) allocated to the control group (RR 
0.90 95% CI 0.64 to 1.26; RD −3.5% (95% CI −14.9% to 7.8%)) 
(table 4). Overall, 251 babies (94%) had a cranial ultrasound scan 
(127 vs 124, respectively), and both adjudicated scan and review of 
the original clinical scan report were available for 224/266 (84%). 
Diagnosis of IVH was based on adjudication for 81 infants, scan 
report only for 8 and site data only for 1. There were no clear differ-
ences between the allocated groups for any other outcome (table 4).
Outcome for women
There was no clear difference between the groups in blood 
loss at birth (≥500 mL 58/130 vs 59/124, RR 0.97, 0.71 to 
1.35; ≥1000 mL 11/130 vs 13/124; RR 0.81, 0.38 to 1.73), or 
in any other outcomes for the women (table 5).
DIscussIOn
This trial suggests that cord clamping after at least 2 min 
and providing neonatal care with cord intact may improve 
outcome at discharge for the infants compared with early 
clamping and neonatal care after clamping, but the CIs are 
wide and include harm. We achieved a substantial differ-
ence of 109 s between the two groups in median time to 
clamping, and neonatal care at birth was equivalent in the 
two groups. For 82% of infants allocated clamping after at 
least 2 min umbilical flow continued for longer than in the 
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table 3 Mortality for the baby before discharge from hospital
clamp ≥2 
min+neonatal 
care with cord 
intact
clamp ≤20 
s+neonatal care 
after clamping
(n=135) (n=135)*
Death 7 (5%) 15 (11%)
  Stillbirth 1 2
  Early neonatal death 3 7
  Late neonatal death 2 5
  Postneonatal death 1 1
Gestation at birth (weeks)
  30–31+6 – 1
  28–29+6 1 3
  26–27+6 – 4
  <26 6 7
Cause of death:
  Congenital anomaly† – 1
  Severe pulmonary immaturity 3 3
  Intrapartum asphyxia 1 1
  IVH 1 2
  Infection
    Antepartum – 1
    Early onset 1 1
    Late onset – 2
  Necrotising enterocolitis – 2
  Other‡ 1 2
*Includes the baby of one woman who withdrew.
Clamp ≥2 min: prolonged oligohydramnios (n=1); clamp ≤20 s: myocardial 
ischaemia (1), prolonged oligohydramnios (1).
†Not known before randomisation.
table 4 Neonatal morbidity for liveborn babies
clamp ≥2 
min+neonatal 
care with cord 
intact
clamp ≤20 
s+neonatal care 
after clamping
(n=134) (n=132)
Any IVH (grade1–4) 43 (32%) 47 (36%)
  Alive at discharge from hospital 38 42
Severe IVH (grade 3 or 4) 6 (4%) 7 (5%)
Periventricular leukomalacia 7 (5%) 8 (6%)
Other brain injury 5 (4%) 10 (8%)
  Porencephalic cysts – 1
  Ventriculomegaly – 3
  Other* 5 7
Heart rate <100 at 1 min 46† (34%) 49 (37%)
Temperature, admission to NICU (°C) mean 
(SD) 36.7 (0.6)‡
36.9 (0.8)
  ≤36°C 17 (13%) 14 (11%)
  ≤35°C 2 (1%) 3 (2%)
Blood transfusion (any) 63 (47%) 68 (52%)
  For anaemia 58 66
  For hypotension – 6
  Other indication 4 7
Jaundice requiring treatment 123 (92%) 120 (91%)
  Phototherapy 123 120
  Exchange transfusion – –
Polycythaemia requiring intravenous fluids – 1 (1%)
Chronic lung disease§ 40 (31%) 39 (33%)
Ventilation 100 (75%) 103 (78%)
  Duration (days), median (IQR) 3 (1, 9) 2 (1, 9)
Necrotising enterocolitis 8 (6%) 5 (4%)
  X-ray with perforation or pneumatosis 7 3
  Laparotomy 6 3
Suspected necrotising enterocolitis¶ 15 (11%) 13 (10%)
Sepsis 72 (53%) 80 (61%)
  Positive culture+antibiotics ≥5 days 30 33
  Negative culture+antibiotics ≥5 days 42 47
Treatment for:
  Patent ductus arteriosus 20 (15%) 20 (15%)
  Retinopathy of prematurity§ 5 (4%) 5 (4%)
Duration of hospital stay** (days) median 
(IQR) 57 (39, 85) 57 (38, 75)
Mother’s breast milk at discharge**†† 71 (55%) 68 (57%)
*Clamp ≥2 min: prominent subarachnoid spaces suggestive of atropy (n=2), 
periventricular cyst (1), absent cavum septum pellucidum (1), occipital cyst 
(1). Clamp ≤20 s: prominent subarachnoid spaces suggestive of atropy (n=2), 
periventricular echodensities (1), increased echogenicity of deep white matter (1), 
mega cysterna (1), ventriculitis (1) and marked ventricular asymmetry (1).
†Not known n=2.
‡Temperature not recorded for two babies.
§Babies who survived to 36 weeks postmenstrual age: n=129 clamping ≥2 min, 
n=120 clamping ≤20 s. Data collected at 36 weeks postmenstrual age, or discharge 
whichever happened first.
¶Defined as bowel rest+antibiotics ≥5 days.
**Admitted to neonatal unit and alive at discharge: n=128 clamping ≥2 min; 
n=120 clamping ≤20 s
††Not known n=3 clamping ≥2 min; n=1 clamping ≤20 s.
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control group, as the cord was clamped after 20 s. Providing 
neonatal care with cord intact required a multidisciplinary 
team approach, planning and training. For the neonatal 
teams, training was consistent with newborn life support 
recommendations,14 15 and included communication with the 
woman, her partner and other clinical staff. The decision to 
intubate was based on local hospital policy; the risk of intu-
bation was similar in the two allocated groups, and consis-
tent with the UK practice.29 Our study demonstrates that 
neonatal care with the cord intact is feasible using a range 
of procedures, and can be done with existing resuscitation 
equipment19 or with a trolley designed for this purpose.18 23 
This is a more practical and potentially more widely gener-
alisable strategy for supporting continued umbilical flow at 
birth than in other trials to date.
This study was not powered to detect differences between 
the allocated interventions. Nevertheless, the most striking 
result is the difference in death before discharge, this is 
based on a small number of events however with a wide 
CI that cannot rule out any difference. Also, there are no 
clear differences between the groups in IVH or any other 
serious morbidity that would potentially explain a differ-
ence in mortality. Hence, this difference probably reflects 
the play of chance.
Bringing neonatal care to the mother’s bedside allows 
her and her partner to share the first moments of their 
child’s life. Family presence during resuscitation is stan-
dard for other areas of healthcare, where it is preferred by 
families and appears to be beneficial.30–33 Our preliminary 
work suggests neonatal care beside the mother is accept-
able to women and their partners,34 and to clinicians.18 35 
Nevertheless, some women reported negative emotions,34 
and clinicians, particularly those with less experience, were 
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table 5 Outcome for the women
clamp ≥2 
min+neonatal 
care with cord 
intact
clamp 
≤20 s+neonatal 
care after 
clamping
n=130 n=124
Blood loss at birth
  ≥500 mL 58 (45%) 59 (48%)
  ≥1000 mL 11 (8%) 13 (10%)
For vaginal births*
  manual removal of placenta 5 (10%) 6 (11%)
  Third stage>30 min 4 (8%) 6 (11%)
Blood transfusion 5 (4%) 3 (2%)
Postpartum infection+parenteral antibiotics 34 (26%) 29 (23%)
Fever >38°C 8 (6%) 5 (4%)
Duration of hospital stay (days) median (IQR) 4 (2, 6) 4 (2, 6)
Expressing/breast feeding at discharge† 121 (96%) 111 (93%)
*n=48 clamping ≥2 min; n=57 clamping ≤20 s.
†For women whose babies were alive at time of their discharge, n=126 
clamping ≥2 min; n=120 clamping ≤20 s.
Original article
concerned about ‘performing’ in front of the parents.35 Few 
babies in these studies required resuscitation, however, and 
further evaluation is required.
In our study, median birth weight was lower, rather than 
higher, for infants allocated deferred clamping; suggesting 
that net change in neonatal blood volume may not be relevant 
for very preterm births and supporting our hypothesis that 
continued umbilical flow has a role in the expanding pulmonary 
circulation during transition to the neonatal circulation.
strengths and limitations of this study
Previous trials have largely excluded infants needing immediate 
resuscitation at birth.15 We developed two strategies that enabled 
us to recruit these high-risk births. First, providing resuscitation 
with cord intact as needed allowed infants requiring immediate 
resuscitation at birth to be included. Second, if birth was immi-
nent leaving insufficient time for the usual consent process, 
women were offered the opportunity to participate through a 
two-stage oral assent pathway; a quarter of recruitment used this 
pathway. The two-stage approach seems acceptable to women 
and to clinicians.36 Other strengths are that the study was multi-
centre and conducted within existing clinical services, hence 
widely generalisable to similar settings, and that independent 
adjudication of cranial ultrasound scans improved reliability in 
ascertainment of IVH.37
Although the largest preterm cord clamping trial published 
to date, this trial was not powered to demonstrate clinically 
important differences in outcome between the two policies, 
therefore the key limitation is sample size.
comparison with other studies
One previous trial comparing alternative policies for timing 
of cord clamping (46 babies) has described providing neonatal 
care with the cord intact,38 but the only outcome reported was 
neonatal blood volume. Other trials comparing alternative 
policies for cord clamping do not report providing immediate 
neonatal care with cord intact. One recent trial (150 babies) has 
evaluated ventilation with cord intact for infants born before 32 
weeks gestation, but in this study cord clamping was at 60 s in 
both intervention arms.39
The Cochrane review includes 15 trials (738 babies) 
before 37 weeks gestation.11 Restricting this to trials largely 
recruiting before 32 weeks and excluding those evaluating 
cord milking leaves 12 trials (552 babies) with deferred 
clamping between 30 and 120 s. In these trials, 8/236 (3.4%) 
babies allocated deferred clamping died compared with 
14/250 (5.6%) allocated immediate clamping, and IVH was 
31/195 (16%) vs 50/199 (25%), respectively. These event 
rates are substantially lower than in our trial, as high-risk 
infants requiring resuscitation at birth were not recruited. 
In our study, the overall mortality at discharge from hospital 
(8.1%) is comparable to that reported for infants of a similar 
gestation admitted to the 37 UK neonatal units participating 
in the Vermont Oxford Network (for 1116 inborn infants 
born between 24 and 31 weeks gestation during 2015, 
mortality at discharge was 10.8%).40 This provides reassur-
ance that we successfully recruited a generalisable group of 
babies. Diagnosis of any IVH (34%) is higher than reported 
in the UK for similar babies (27%),40 but reassuringly severe 
IVH is similar (5% and 6%, respectively). Hence, the differ-
ence in any IVH diagnosis is likely to be due to variation 
in the grade 1 and 2 IVH, with another potential factor 
being differences between hospitals in the proportions of 
infants born before 32 weeks gestation who have a cranial 
ultrasound scan. Although some previous studies reported 
that cranial ultrasound scans were conducted blind to the 
allocation, none have reported independent adjudication of 
the scan diagnosis.
Other issues with the trials included in the Cochrane 
Review are that only two appear to have been registered. 
This may be relevant since most studies reported mortality, 
the definition (eg, including or excluding major congen-
ital abnormality and/or stillbirth) varied, and of 11 other 
outcomes none were reported by more than 6 out of the 
15 trials: therefore, selective outcome reporting must be at 
least a possibility. The apparently high compliance noted in 
some previous trials seems rather implausible and raises the 
possibility of unreported postrandomisation exclusions, and 
hence further potential for bias.
Resuscitation guidelines state 'there is insufficient evidence to 
recommend an appropriate time for clamping the cord in infants 
who are severely compromised at birth, and that for infants 
requiring resuscitation, resuscitative intervention remains the 
immediate priority’.15 Clearly, uncertainty remains about when 
to clamp the cord for infants requiring resuscitative interven-
tions. For preterm infants who are stable at birth and do not 
require resuscitation, recommendations are to wait at least 30 s 
and no longer than 3 min.15 41
Cord milking is advocated to increase neonatal blood volume 
without needing to defer cord clamping.42 This technique 
disrupts umbilical blood flow, however, over-riding autoregula-
tion of blood volume and blood pressure. As a different inter-
vention to cord clamping, with greater potential to do harm, it 
requires rigorous evaluation.43–45
cOnclusIOns
A large multicentre trial is urgently needed to confirm whether 
a long delay (2 min or more) in cord clamping combined with 
stabilisation and/or resuscitation with cord intact, rather than 
standard care, really does improve outcome for very preterm 
births. This study demonstrates that such a trial is feasible.
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